Trial intelligence / Profile preview

Adefovir Dipivoxil vs Adefovir Dipivoxil + Lamivudine in Chronic Hepatitis B

NCT00230477Phase 4Completed

Sponsor
University of Washington
Start
Apr 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of adefovir dipivoxil, lamivudine in Chronic Hepatitis B (CHB), sponsored by University of Washington. Started Apr 2003; status: completed.

02

Drugs

adefovir dipivoxillamivudine
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT00230477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00230477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call